Atrion Corporation Announces Election of New Director
21 September 2023 - 6:29AM
Atrion Corporation (NASDAQ: ATRI) announced the election today of
Jeannette Bankes as a director, effective immediately.
Ms. Bankes brings to our Board over 32 years of experience at
major medical device and pharmaceutical companies. Since March
2019, Ms. Bankes has served as the President and General Manager of
the Global Surgical Franchise at Alcon Inc. From August 2004 to
March 2019, Ms. Bankes served in leadership positions across
multiple divisions and functions at Boston Scientific Corporation,
including as General Manager, Urology and Pelvic Health. Prior to
joining Boston Scientific, Ms. Bankes worked for Merck & Co.
Ms. Bankes holds a B.S. degree from Kutztown University.
Emile A. Battat, Chairman of the Board, stated, “We are excited
to welcome Jeannette to the Board. She’s made an incredible impact
across the medical device and pharmaceutical industries, and we
look forward to working closely with her.”
Atrion Corporation develops and manufactures products
primarily for medical applications. The Company’s website
is www.atrioncorp.com.
|
Contact: |
Cindy Ferguson |
| |
Vice President and Chief
Financial Officer |
| |
(972) 390-9800 |
ATRION (NASDAQ:ATRI)
Historical Stock Chart
From Mar 2024 to Apr 2024
ATRION (NASDAQ:ATRI)
Historical Stock Chart
From Apr 2023 to Apr 2024
